Robert G.Dutcher
Director since 1993
Chairman, President and Chief Executive Officer

Mary K.Brainerd
Director since 2001
President and Chief Executive Officer, HealthPartners, Inc., Minneapolis, Minnesota

Seymour J. Mansfield
Director since 1987
Officer and Shareholder,
Mansfield, Tanick & Cohen, P.A., Attorneys,
Minneapolis, Minnesota

William C.Mattison, Jr.
Director since 1999
Retired. Formerly Principal of Gerard, Klauer, Mattison & Co., Inc.,
New York, New York

Whitney A. McFarlin
Director since 1998
Retired. Formerly Chairman, President and Chief Executive Officer, Angeion Corporation

Donald C. Wegmiller
Director since 1987
Senior Consultant and Advisor,
Clark Consulting,
Minneapolis, Minnesota

Rodney A. Young
Director since 1999
President and Chief Executive Officer, Angeion Corporation,
St. Paul, Minnesota

Robert G. Dutcher
President, Chairman and Chief Executive Officer

Jules L. Fisher
Vice President, Finance and Chief Financial Officer

Irving R. Colacci
Vice President, Legal Affairs and Human Resources, General Counsel and Secretary, Chief Governance Officer

James D. Gustafson
Senior Vice President, Research, Development, Engineering,
Clinical Evaluation and Chief Quality Officer

Shawn F. McCarrey
Executive Vice President,
Worldwide Sales and Marketing

Robert J. Scott
Vice President, Manufacturing
Operations & IT and
Chief Security Officer

Auditors
Deloitte & Touche LLP,
Minneapolis, MN

Legal Counsel
Dorsey & Whitney LLP,
Minneapolis, MN

Transfer Agent
Wells Fargo Minnesota, N.A.
Shareowner Services
161 North Concord Exchange
P.O. Box 738
South Saint Paul, MN 55075-0738
Phone: (800) 468-9716

Investor Information
Shareholders, security analysts and investors seeking additional information about the Company should call Investor Relations at (763) 780-4555. The following information may be obtained upon request from the Possis Medical Investor Relations Department, 9055 Evergreen Boulevard, N.W. Minneapolis, MN 55433-8003, USA:

• News releases describing significant Companyevents and sales and earnings results foreachquarter and the fiscal year.
  
• Form 10-K Annual and Form 10-Q QuarterlyReports to the Securities and ExchangeCommission detailing Possis’ business and financial condition.

News releases and other information can beaccessed via the Internet at www.possis.com

Annual Meeting
The annual meeting will be held at Dorsey & Whitney LLP, 50 South Sixth Street,15th Floor, Minneapolis, MN, on December 13, 2006, at 4:00 p.m.

Form 10-K
A copy of the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission will be providedto shareholders without charge upon written request.

Market for the Registrant’s Common Equity,Related Stockholder Matters and Issuer Purchases of Equity Securities:
We had 1,253 common shareholders of record on September 21, 2006. Our common stockis traded on the Nasdaq Stock Market underthe symbol POSS. High and low closing saleprices for each quarter of fiscal years ended July 31, 2006 and 2005 are presented below: